Akebia Therapeutics, Inc. - Common Stock (NQ:AKBA)

0.8785 -0.0320 (-3.51%)

Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Akebia Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday ↗

July 05, 2022

Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.

Via Benzinga

REV Stock Moves Amid Revlon Bankruptcy, Short Squeeze Hopes ↗

July 01, 2022

Revlon (REV) stock is on the move Friday as the volatility surrounding the meme stock continues following its bankruptcy announcement.

Via InvestorPlace

Why Are Akebia Therapeutics Shares Falling Today? ↗

May 16, 2022

Via Benzinga

U.S Stocks Turn Lower; Dow Tumbles Over 100 Points ↗

July 01, 2022

U.S. stocks turned lower midway through trading, with the Dow Jones dropping more than 100 points on Friday.

Via Benzinga

Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.

Via Benzinga

Why Is Akebia Therapeutics (AKBA) Stock Up 14% Today? ↗

July 01, 2022

Akebia Therapeutics (AKBA) stock is taking off on Friday after the kidney treatment company revealed the return of rights for vadadustat.

Via InvestorPlace

Why U.S. Stocks Are Trading Higher, Manufacturing Report And More ↗

July 01, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday.

Via Benzinga

The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact ↗

July 01, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 01, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 01, 2022

Good morning, trader! It's time for another look at the biggest pre-market stock movers as we dive into the latest news for Friday!

Via InvestorPlace

Akebia Therapeutics And 20 Stocks Moving Premarket ↗

July 01, 2022

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 83.2% to $0.8250 in pre-market trading after dropping 10% on Thursday.

Via Benzinga

Micron, Akebia Therapeutics And 3 Stocks To Watch Heading Into Friday ↗

July 01, 2022

Some of the stocks that may grab investor focus today are:

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 30, 2022

Gainers

Via Benzinga

Why Akebia Therapeutics Stock Is Soaring After Hours ↗

June 30, 2022

Akebia Therapeutics Inc (NASDAQ: AKBA) shares are surging in Thursday's after-hours session after the company executed an agreement to terminate its Vadadustat collaboration and license agreements with...

Via Benzinga

Aspen Aerogels And 28 Stocks Moving Premarket ↗

June 30, 2022

Gainers

Via Benzinga

This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday ↗

June 30, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

Akebia Therapeutics (AKBA) Stock Soars 18% Despite Lack of News ↗

June 29, 2022

AKBA stock is up big, but the lack of news is concerning considering that Akebia Therapeutics already faces a regulatory setback.

Via InvestorPlace

Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session ↗

June 29, 2022

Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 29, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 29, 2022

Good morning, trader! With the start of another day comes our breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗

June 20, 2022

San Diego, CA -- (SBWIRE) -- 06/20/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Akebia Therapeutics, Inc..

Via SBWire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 15, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 15, 2022

It's time for another breakdown of the biggest pre-market stock movers as we get ready for the opening bell on Wednesday!

Via InvestorPlace

18 Stocks Moving in Thursday's Pre-Market Session ↗

June 09, 2022

Gainers View, Inc. (NASDAQ: VIEW) rose 18.5% to $2.05 in pre-market trading after declining 5% on Wednesday.

Via Benzinga

Looking Into Akebia Therapeutics's Return On Capital Employed ↗

June 02, 2022

According to Benzinga Pro data, during Q1, Akebia Therapeutics (NASDAQ:AKBA) posted sales of $61.70 million. Earnings were up 11.68%, but Akebia Therapeutics still reported an overall loss of $62.42...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 31, 2022

Gainers

Via Benzinga

41 Stocks Moving In Monday's Mid-Day Session ↗

May 16, 2022

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Via Benzinga

73 Biggest Movers From Yesterday ↗

May 17, 2022

Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

Via Benzinga

Expert Ratings for Akebia Therapeutics ↗

May 16, 2022

Over the past 3 months, 4 analysts have published their opinion on Akebia Therapeutics (NASDAQ:AKBA) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

May 16, 2022

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.